Sadhna M Shankar
Overview
Explore the profile of Sadhna M Shankar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rhodes M, Akohoue S, Shankar S, Fleming I, An A, Yu C, et al.
Pediatr Blood Cancer
. 2009 Jun;
53(4):635-41.
PMID: 19544390
Background: Previous studies of children with homozygous sickle cell anemia (SCA) show impaired growth and maturation. The correlation of this suboptimal growth with metabolic and hematological factors during puberty is...
2.
Prasad P, Sun C, Baker K, Francisco L, Forman S, Bhatia S, et al.
Cancer
. 2008 Oct;
113(10):2724-33.
PMID: 18831512
Background: Long-term hematopoietic cell transplantation (HCT) survivors have a high prevalence of severe and chronic health conditions, placing significant demands on the healthcare system. The objective of the current study...
3.
Shankar S, Marina N, Hudson M, Hodgson D, Adams M, Landier W, et al.
Pediatrics
. 2008 Jan;
121(2):e387-96.
PMID: 18187811
Curative therapy for childhood cancer has improved significantly in the last 2 decades such that, at present, approximately 80% of all children with cancer are likely to survive > or...
4.
Shankar S, Nania J
Paediatr Drugs
. 2007 Oct;
9(5):301-9.
PMID: 17927302
Pneumocystis jiroveci (formerly carinii) pneumonia (PCP) is a serious opportunistic infection in children and adolescents with cancer. It was the most common cause of death among children receiving chemotherapy prior...
5.
Buchowski M, Swift L, Akohoue S, Shankar S, Flakoll P, Abumrad N
JPEN J Parenter Enteral Nutr
. 2007 Jun;
31(4):263-8.
PMID: 17595432
Background: The chronic hemolytic anemia experienced by sickle cell disease (SCD) patients leads to adverse effects on oxygen transport by the blood and to a decrease in oxygen availability for...
6.
Halasa N, Shankar S, Talbot T, Arbogast P, Mitchel E, Wang W, et al.
Clin Infect Dis
. 2007 May;
44(11):1428-33.
PMID: 17479937
Background: We sought to determine the incidence of invasive pneumococcal disease (IPD) among individuals with sickle cell disease (SCD) before and after the introduction of the pneumococcal conjugate vaccine (PCV)....
7.
Prasad P, Nania J, Shankar S
Pediatr Blood Cancer
. 2007 Apr;
50(4):896-8.
PMID: 17458875
Pneumocystis pneumonia (PCP) is a serious complication of chemotherapy-induced immunosuppression. Trimethoprim-sulfamethoxazole (TMP-SMZ) given twice daily, 3 days every week is considered the best form of prophylaxis for PCP. We evaluated...
8.
Shankar S, Carter A, Sun C, Francisco L, Baker K, Gurney J, et al.
Cancer Epidemiol Biomarkers Prev
. 2007 Apr;
16(4):834-9.
PMID: 17416780
The high intensity of therapy and prolonged immune suppression after hematopoietic cell transplantation (HCT) increase the risk of long-term complications and health care needs among survivors. The aim of this...
9.
Shankar S, Arbogast P, Mitchel E, Ding H, Wang W, Griffin M
Pediatr Blood Cancer
. 2006 Sep;
50(1):66-71.
PMID: 16998856
Background: The impact of comprehensive care on utilization of healthcare services by children with sickle cell disease (SCD) has not been fully evaluated. We compared the medical care utilization and...
10.
Shankar S, Arbogast P, Mitchel E, Cooper W, Wang W, Griffin M
Am J Hematol
. 2005 Nov;
80(4):262-70.
PMID: 16315251
The purpose of this study was to evaluate the pattern of medical care utilization and mortality in children and adults with sickle cell disease (SCD) in the state of Tennessee....